aa
All manuscripts submitted to the Korean Journal of Medicine should conform to the following author’s instructions, and if not specified below, must comply with Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals (http://www.icmje.org/recommendations/).
The manuscripts submitted to the Korean Journal of Internal Medicine should be unique and creative that could contribute to the novel findings in the pathology, diagnosis and treatment of diseases. These include perspectives, review articles (What’s hot?, What’s new?, In-depth review, Clinical practice (Road map to diagnosis, Interpretation of a diagnostic test)), original articles, and case reports. All review articles should be submitted and published by the request of the Editorial Board. The manuscript should not have been published elsewhere and must not be submitted simultaneously to any other journal. All manuscripts should be prepared in grammatically correct Korean. All medical terms used should be those listed in the latest terminology book of the Korean Medical Association. Original articles and case reports written in English will be published in English after the review process by the editors. The copyright for articles published in our journal is fully reserved by the Korean Journal of Medicine.
The policies on the research and publication ethics of The Korean Journal of Medicine are followed by ‘Good Publication Practice Guidelines for Medical Journals
(https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=)’ or ‘Guidelines on good publication (https://publicationethics.org/guidance/Guidelines)’.
1) All clinical research must be registered by national clinical research center (https://cris.nih.go.kr/cris/index/index.do), WHO, or institutions certified by ‘International Committee of Medical Journal Editors’
2) Conflict of interestsAuthors must certify that any financial interests such as employment, stock ownership, honoraria, paid expert testimony, as well as any personal relationships, academic competition, and intellectual passion which may inappropriately influence the actions, have been included within my manuscript.
3) Consent formAuthors must keep the patient consent form for clinical trials as well as the study approval form certified by the Institutional Review Board. Authors must submit these documents when requested by the Korean Journal of Medicine.
4) Rules and regulations for human and animal researchResearch using human subjects must conform to the Declaration of Helsinki (revised edition, 2013). Animal studies must be approved by the Institutional Animal Care and Use Committee and these document must be submitted upon request by the Korean Journal of Medicine.
5) AuthorsAll authors must have seen and approved the final version of the manuscript, and all subsequent versions. All authors should have made 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy of integrity of any part of the work are appropriately investigated and resolved.
6) Publication and originalityThe manuscript should not have been published elsewhere and must not be submitted simultaneously to any other journal.
7) Re-printRe-print of the manuscript is possible if guidelines of the ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals’ is satisfied.
1) At least two experts in the given field review whether a submitted manuscript is publishable through the Journal. Based on their reviews, the editorial committee decides whether to publish the manuscript and recommends the author to revise and modify the manuscript when needed. Once the manuscript is revised/modified based on the recommendations, the revised version would be submitted again through the online submission and review system. At this time, the author needs to submit the original version of the manuscript, the modified version and a letter describing how the recommendations are met. In the modified version, any modification and revision made by the author need to be marked in red.
2) The revised manuscript with answers to the questions raised by reviewers should be submitted through the online submission and review system within 30 days. If this deadline is not met, the review process is concluded and the manuscript can not be published unless there is a special reason.
3) When the author is asked for the final revision once the review process is completed, he/she has to submit the revised version within one week.
The Author of the Article as specified herein, hereby transfers copyright to Korean Journal of Medicine effective if and when the article is accepted for publication. The author warrants that his/her contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. The copyright transfer covers the exclusive right to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.
1) All manuscripts can be submitted though the online submission and review system (https://submit.ekjm.org). And also, subsequent reviews and editing are done through this homepage. Manuscript submission, review criteria and solutions to technical problems arising during the submission and review processes can be confirmed through this homepage as well. Manuscript can be submitted only by the corresponding author and first author through the online submission and review system. Additional help may be obtained by email (kaim@kams.or.kr), telephone (+82-2-2271-6791) or fax (+82-2-790-0993).
2) The answers to the questions regarding manuscript review and its process can be found in the online submission and review system at any time. When any change occurs in the review stage, the corresponding author and first author are notified.
All materials must be written in clear, appropriate English. The manuscript must be written in 12-point font with double-line spacing and at least 3-cm margins on A4 or letter-size paper using Microsoft Word or other major word processing programs. All pages should be numbered consecutively starting with the title page. All measurements should be in metric units.
2) Reporting guidelines for specific study designs:For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies and non-randomized studies, it is recommended that the authors follow the reporting guidelines listed in the following Table [1].
Initiative | Type of study | Source |
---|---|---|
CONSORT | Consolidated Standards of Reporting Trials | http://www.consort-statement.org |
STARD | Standards for Reporting of Diagnostic accuracy studies | http://www.stard-statement.org |
PRISMA | Preferred Reporting Items of Systematic Reviews and Meta-Analyses | http://www.prisma-statement.org |
STROBE | Strengthening the Reporting of Observational studies in Epidemiology | http://www.strobe-statement.org |
MOOSE | Meta-analysis of Observational Studies in Epidemiology | http://www.consort-statement.org/mod_product/uploads/MOOS%20Statement%202000.pdf |
Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
Original ArticlesThe following items are written in the cover page.
The English abstract is placed following the cover page.
Background/Aims: The purpose of the paper is described concisely and clearly in one to two sentences. It should in accord with the title of the manuscript and the content of introduction.
Methods: What and how things are done specifically to achieve the purpose described in the first paragraph are described in this section. This section also contains information regarding what data were collected, how data were analyzed and how the bias was adjusted.
Results: The contents of the previous section are described regarding how the observation and analysis were made logically and the specific data are presented.
Conclusions: The conclusion drawn from the results is described in one to two sentences, befitting the purpose described in the first section.
Journal articles:
1. Yoo BM, Lehman GA. Update on endoscopic treatment of chronic pancreatitis. Korean J Intern Med 2009;24:169-179.
2. Caselli RJ, Dueck AC, Osborne D, et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 2009;361:255-263.
Entire book:
3. Gilman AG, Rall TW, Nies AS, Taylor P. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 9th ed. New York: Pergamon Press, 1996.
Part of a book:
4. Costa M, Furness JB, Llewellyn-Smith IF. Histochemistry of the enteric nervous system. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 2nd ed. Vol. 1. New York: Raven, 1987:1-40.
Dissertation:
5. Hong GD. The relationship between low serum cholesterol level and cancer mortality [dissertation]. Seoul (KR): Seoul National University, 2009.
Conference paper:
6. Rice AS, Brooks JW. Canabinoids and pain. In: Dostorovsky JO, Carr DB, eds. Proceedings of the 10th World Congress on Pain; 2002 Aug 17-22; San Diego, CA. Seattle (WA): IASP Press, 2003:437-468.
Online publication:
7. Suzuki S, Kajiyama K, Shibata K, et al. Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Ann Oncol 2008 Mar 19 [Epub]. http://dx.doi.org/10.1093/annonc/mdn059.
Online sources:
8. American Cancer Society. Cancer reference information [Internet]. Atlanta (GA): American Cancer Society, c2009 [cited 2009 Nov 20]. Available from: http://www.cancer.org/docroot/CRI/CRI_0.asp.
9. National Cancer Information Center. Cancer incidence [Internet]. Goyang (KR): National Cancer Information Center, c2009 [cited 2009 Oct 20]. Available from: http://www.cancer.go.kr/cms/statics.
Perspectives address current topics in medical policy or problems including public health, insurance, ethics, and political issues and projects of the Korean Association of Internal Medicine. An unstructured abstract of less than 250 words should be placed after the title page before the main body. Otherwise, these articles can be written freely without any specific format. The text should have maximum 1,000 words.
2) Review articles
Review articles discuss about specific topics which will be submitted by specific authors who are requested by the editorial committee. Submitted manuscripts are published after review process. The articles are categorized as ‘What’s hot?’, ‘What’s new?’, ‘In-depth review’ and ‘Clinical practice’.
‘What’s hot?’ covers medical and academic issues which can entertain our readership. The text should have maximum 1,500 words including unstructured abstract in English.
‘What’s new?’ covers new guidelines, new clinical research findings and medications which can broaden knowledge of our readership. The text should have maximum 3,000 words with unstructured abstract in English.
‘In-depth review’ covers topics about common diseases in the field of Internal Medicine which provide continuing medical education. The text should have maximum 2,000 words with unstructured abstract in English.
‘Clinical practice’ is composed of ‘Road map to diagnosis’ and ‘Interpretation of a diagnostic test’.
‘Road map to diagnosis’ presents symptom-based approach for diagnosis, that is actual scenario about specific symptoms or conditions followed by practical algorithm to diagnosis. Authors should present a brief case of a patient with specific symptoms or abnormal conditions, and then describe step by step processes for final diagnosis. The treatment course is followed and simply described. The text should have a maximum 1,500 words, consisting of no more than 1,500 words for the case presentation, followed by problem, diagnostic steps, management, clinical course and short discussion. The text should have no more than 10 references (negotiable).
‘Interpretation of a diagnostic test’ covers interpreting methods and clinical application of laboratory tests and imaging studies. This manuscript covers interpretation for commonly used and typical diagnostic tests and imaging methods. The text should have a maximum 2000 words with no more than 10 references (negotiable).
All manuscripts are required to have conflict of interest, funding, acknowledgements between the main body and references.
3) Case reportsEffective from January 1, 2015, an article processing charge of $300 (₩300,000 KRW) for original articles and $200 (₩200,000 KRW) for case reports will be applicable for articles accepted for publication in the Korean Journal of Medicine. Submission of the article to the journal can be completed once the payment method has been agreed. Any applicable article processing charge must be paid prior to publication.
A preprint can be defined as a version of a scholarly paper that precedes formal peer review and publication in a peer-reviewed scholarly journal. KJM allows authors to submit the preprint to the journal. It is not treated as duplicate submission or duplicate publication. KJM recommend authors to disclose it with DOI in the letter to the editor during the submission process. Otherwise, it may be screened from the plagiarism check program — Similarity Check (Crosscheck).
Preprint submission will be processed through the same peer-review process with a usual submission. If the preprint is accepted for publication, authors are recommended to update the info at the preprint with a link to the published article in KJM, including DOI at KJM. It is strongly recommended that authors cite the article in KJM instead of the preprint.
Korean Journal
of Medicine
Print ISSN: 1738-9364
Online ISSN: 2289-0769